April Barbour
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Bacterial Identification and Susceptibility Testing 5
- Pharmacology 11
- Antibiotics Pharmacokinetics and Efficacy 10
- Co-authors
- Hartmut DerendorfStephan SchmidtKenneth H. RandMichael J. FosslerOlaf BurkhardtFrancesco ScaglioneStephanie SchmidtJohn J. Lepore
- Journals
- The Journal of Clinical Pharmacology (7 papers)International Journal of Antimicrobial Agents (4 papers)Antimicrobial Agents and Chemotherapy (2 papers)Blood (2 papers)Cardiovascular Diabetology (1 paper)
- Partner nations
- United StatesUnited KingdomFinland
In The Last Decade
April Barbour
30 papers receiving 686 citations
Peers
Comparison fields: 5 of 80
- Molecular Medicine 152
- Applied Microbiology and Biotechnology 33
- Pharmacology 259
- Clinical Biochemistry 74
- Internal Medicine 40
Countries citing papers authored by April Barbour
This map shows the geographic impact of April Barbour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by April Barbour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites April Barbour more than expected).
Fields of papers citing papers by April Barbour
This network shows the impact of papers produced by April Barbour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by April Barbour. The network helps show where April Barbour may publish in the future.
Co-authors
The 25 scholars most cited alongside April Barbour, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 7 | |
| 2 | 2024 | 5 | |
| 3 | 2019 | 3 | |
| 4 | 2018 | 4 | |
| 5 | 2018 | 3 | |
| 6 | 2017 | 8 | |
| 7 | 2017 | 15 | |
| 8 | 2016 | 108 | |
| 9 | 2016 | 10 | |
| 10 | 2014 | 10 | |
| 11 | 2013 | 21 | |
| 12 | 2013 | 44 | |
| 13 | 2011 | 47 | |
| 14 | 2010 | 46 | |
| 15 | 2009 | 63 | |
| 16 | 2009 | 49 | |
| 17 | 2009 | 61 | |
| 18 | 2009 | 16 | |
| 19 | 2009 | 32 | |
| 20 | 2008 | 70 |
About April Barbour
April Barbour is a scholar working on Clinical Biochemistry, Pharmacology, Molecular Medicine, Hematology and Infectious Diseases, having authored 30 papers that have together received 700 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (10 papers), Antimicrobial Resistance in Staphylococcus (6 papers), Bacterial Identification and Susceptibility Testing (5 papers), Antibiotic Resistance in Bacteria (3 papers), Chronic Myeloid Leukemia Treatments (3 papers), Diabetes Treatment and Management (3 papers), Pharmaceutical studies and practices (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). The work is most often cited by research in Molecular Medicine (152 citations), Applied Microbiology and Biotechnology (33 citations), Pharmacology (259 citations), Clinical Biochemistry (74 citations) and Internal Medicine (40 citations). April Barbour has collaborated with scholars based in United States, United Kingdom and Finland. Frequent co-authors include Hartmut Derendorf, Stephan Schmidt, Kenneth H. Rand, Michael J. Fossler, Olaf Burkhardt, Francesco Scaglione, Stephanie Schmidt, John J. Lepore, Laura A. Demopoulos and Víctor G. Dávila‐Román. Their work appears in journals such as The Journal of Clinical Pharmacology, International Journal of Antimicrobial Agents, Antimicrobial Agents and Chemotherapy, Blood and Cardiovascular Diabetology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.